US2008004219A1PendingUtilityA1

Method for treating smooth muscle disorders with a neurotoxic component of a botulinum toxin

Assignee: ALLERGAN INCPriority: Dec 28, 1993Filed: Feb 15, 2007Published: Jan 3, 2008
Est. expiryDec 28, 2013(expired)· nominal 20-yr term from priority
A61P 25/00A61P 29/00A61P 21/02A61P 19/02A61P 21/00A61K 38/4893A61K 39/08Y02A50/30
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.

Claims

exact text as granted — not AI-modified
1 . (canceled)  
     
     
         6 . A method for treating a smooth muscle disorder, said method comprising administering to the patient a therapeutically effective amount of a neurotoxic component of a botulinum toxin in order to treat a smooth muscle disorder.  
     
     
         14 . A method for relieving a muscle spasm said method comprising administering to a patient a therapeutically effective amount of a neurotoxic component of a botulinum toxin.  
     
     
         21 - 22 . (canceled)  
     
     
         23 . The method of  claim 6 , wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G.  
     
     
         24 . The method of  claim 23 , wherein the botulinum toxin is a botulinum toxin type A.  
     
     
         25 . The method of  claim 14 , wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G.  
     
     
         26 . The method of  claim 25 , wherein the botulinum toxin is a botulinum toxin type A.  
     
     
         27 - 30 . (canceled)

Join the waitlist — get patent alerts

Track US2008004219A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.